BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33937262)

  • 21. Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma.
    L'Hermitte A; Pham S; Cadoux M; Couchy G; Caruso S; Anson M; Crain-Denoyelle AM; Celton-Morizur S; Yamagoe S; Zucman-Rossi J; Desdouets C; Couty JP
    Hepatology; 2019 Jan; 69(1):160-178. PubMed ID: 30070727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis.
    Chen CK; Yu WH; Cheng TY; Chen MW; Su CY; Yang YC; Kuo TC; Lin MT; Huang YC; Hsiao M; Hua KT; Hung MC; Kuo ML
    Sci Rep; 2016 Aug; 6():31398. PubMed ID: 27507763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
    Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
    Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein.
    Li XY; Wu HY; Mao XF; Jiang LX; Wang YX
    Biochem Biophys Res Commun; 2017 Oct; 492(1):48-54. PubMed ID: 28807830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment.
    Chen CK; Yang CY; Hua KT; Ho MC; Johansson G; Jeng YM; Chen CN; Chen MW; Lee WJ; Su JL; Lai TC; Chou CC; Ho BC; Chang CF; Lee PH; Chang KJ; Hsiao M; Lin MT; Kuo ML
    Hepatology; 2014 Mar; 59(3):974-85. PubMed ID: 24114941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
    Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
    Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target.
    Ong HT; Tan PK; Wang SM; Hian Low DT; Ooi LL; Hui KM
    Cancer Gene Ther; 2011 Jun; 18(6):399-406. PubMed ID: 21394108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis.
    Chen L; Xu X; Wen X; Xu S; Wang L; Lu W; Jiang M; Huang J; Yang D; Wang J; Zheng M; Zhou XZ; Lu KP; Liu H
    Cancer Sci; 2019 Aug; 110(8):2442-2455. PubMed ID: 31148345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.
    Takano S; Reichert M; Bakir B; Das KK; Nishida T; Miyazaki M; Heeg S; Collins MA; Marchand B; Hicks PD; Maitra A; Rustgi AK
    Genes Dev; 2016 Jan; 30(2):233-47. PubMed ID: 26773005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DEPDC1B promotes migration and invasion in pancreatic ductal adenocarcinoma by activating the Akt/GSK3β/Snail pathway.
    Liu X; Li T; Huang X; Wu W; Li J; Wei L; Qian Y; Xu H; Wang Q; Wang L
    Oncol Lett; 2020 Nov; 20(5):146. PubMed ID: 32934714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
    Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metadherin promotes metastasis by supporting putative cancer stem cell properties and epithelial plasticity in pancreatic cancer.
    Suzuki K; Takano S; Yoshitomi H; Nishino H; Kagawa S; Shimizu H; Furukawa K; Miyazaki M; Ohtsuka M
    Oncotarget; 2017 Sep; 8(39):66098-66111. PubMed ID: 29029495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis.
    Mehmetoglu-Gurbuz T; Lakshmanaswamy R; Perez K; Sandoval M; Jimenez CA; Rocha J; Goldfarb RM; Perry C; Bencomo A; Neela N; Barragan JA; Sanchez R; Swain RM; Subramani R
    Antioxidants (Basel); 2023 Sep; 12(10):. PubMed ID: 37891871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N2E4, a Monoclonal Antibody Targeting Neuropilin-2, Inhibits Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma
    Wang L; Wang L; Wang S; Zhou Z; Liu Z; Xu P; Luo X; Wu T; Luo F; Yan J
    Front Oncol; 2021; 11():657008. PubMed ID: 34336654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Interaction Between Long Non-coding RNA HULC and MicroRNA-622 via Transfer by Extracellular Vesicles Regulates Cell Invasion and Migration in Human Pancreatic Cancer.
    Takahashi K; Koyama K; Ota Y; Iwamoto H; Yamakita K; Fujii S; Kitano Y
    Front Oncol; 2020; 10():1013. PubMed ID: 32656089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.